Schedule 13G ownership disclosure
CTI BIOPHARMA CORP
Security class unavailable · CUSIP: 12648L601
Event date: 2017-06-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,307,446
- Percent of class
- 7.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-17-000317
- Form type
- SC 13G
- Filer
- CTI BIOPHARMA CORP
- CIK
- CIK 891293
- Filed
- Jun 22, 2017
- Reporting period
- Jun 06, 2017
- Description
- Schedule 13G beneficial ownership